Accessibility Menu
Nutranomics logo

Nutranomics(OTC) NNRX

Current Price$0.00
Market Cap$15.30KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2013)-100%
5 Year-100%
1 Year+0%
1 Month+0%
Nutranomics last closing stock price
MetricPriceDate
Last closeUSD 0.002026-06-26
Nutranomics stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-06-02
1 month+0%USD 0.002026-05-26
3 month+0%USD 0.002026-03-26
Year to date+0%USD 0.002025-12-29
1 year+0%USD 0.002025-06-26
3 year-98%USD 0.002023-06-27
5 year-99.9%USD 0.002021-06-25
Since inception-100%USD 0.752013-09-20

Nutranomics Financials at a Glance

Market Cap

$15.30KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$3.08M

Net Income (TTM)

-$8.07M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

10.98 (High)

Price

$0.00

Volume

3,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

N/A

NNRX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Nutranomics

Nutranomics, Inc. is a company dedicated to the research, development, and marketing of health-focused nutritional products. With a diverse catalog of nearly 500 dietary supplements, Nutranomics aims to enhance health and wellness through innovative solutions.

Products and Services
  • Offers a wide range of dietary supplements, including vitamins, minerals, and probiotics
  • Provides Nutritional Blood Analysis for live observation of blood cells
  • Delivers educational resources and professional certifications for individuals and industry experts
Growth Outlook
  • Recent quarterly revenue increased to $1,008,761, showing potential for growth
  • Strategic alliances, such as with Terra-Formance, may enhance market reach
  • Global distribution network across North America and Asia supports expansion opportunities
Financial Highlights
  • Trailing twelve months (TTM) revenue of $2,175,000 indicates a growing sales trend
  • Net income for the latest quarter was -$1,522,518, reflecting ongoing challenges
  • Cash at the end of the latest quarter was $299,736, providing liquidity for operations
Nutranomics, Inc. operates within the Drug Manufacturers - Specialty & Generic industry, focusing on health and wellness products. The company has developed a comprehensive range of dietary supplements, which are marketed globally through a network of sales representatives and retail stores. The innovative Nutritional Blood Analysis service allows customers to gain insights into their health, while the Assimilation Enhancing System optimizes nutrient absorption. Despite facing financial challenges, including negative net income and operating losses, Nutranomics has shown resilience with a recent increase in quarterly revenue. The strategic partnerships and a robust distribution network position the company for potential growth in the health-focused nutritional market. Investors may find interest in the company's commitment to innovation and its extensive product offerings as it navigates the complexities of the industry.
AI Generated • Jun 29, 2026

Industry

Personal Products

Sector

Consumer Staples

CEO

Jonathan Bishop

Website

www.nutranomics.com

Headquarters

Salt Lake City, UT 84020, US

NNRX Financials

Key Financial Metrics (TTM)

Gross Margin

-108.05%

Operating Margin

-297.40%

Net Income Margin

-232.89%

Return on Equity

99.34%

Return on Capital

-198.21%

Return on Assets

-36.76%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$15.30KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

15.32B

Volume

3.00K

Avg. Volume

94.18K

Financials (TTM)

Gross Profit

-$2.70M

Operating Income

-$8.60M

EBITDA

-$2.55M

Operating Cash Flow

-$3.77M

Capital Expenditure

-$184.50K

Free Cash Flow

-$3.95M

Cash & ST Invst.

$299.74K

Total Debt

$23.97M

Nutranomics Performance Analysis

Nutranomics annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-07-31USD 1,756,918N/A
20222022-07-31USD 2,846,78662.0%
Nutranomics sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42022-07-3117.0%
Q12022-10-31-53.4%
Q22023-01-3149.2%
Q32023-04-3051.1%
Nutranomics annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-07-31USD -0.00N/A
20222022-07-31USD -0.00133.3%
Nutranomics sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42022-07-3190.3%
Q12022-10-3166.7%
Q22023-01-31N/A
Q32023-04-30N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2023YOY CHG

Revenue

$1.01M

+23.0%

Gross Profit

-$249.16K

+82.0%

Gross Margin

-24.70%

N/A

Market Cap

$15.30KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$15.30K

N/A

Employees

1

N/A

Net Income

-$1.52M

-80.6%

EBITDA

-$987.03K

-40.5%

Quarterly Fundamentals

Name
Q3 2023YOY CHG

Total Cash

$299.74K

-9.1%

Total Debt

$23.97M

+24.1%

Accounts Receivable

$840.32K

+32.0%

Inventory

$1.25M

+0.8%

Long Term Debt

$13.74M

+3.1%

Short Term Debt

$10.23M

+70.9%

Return on Assets

-36.76%

N/A

Return on Invested Capital

-3.16%

N/A

Free Cash Flow

$156.24K

+104.1%

Operating Cash Flow

$146.88K

+103.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
VFRMVeritas Farms, Inc.
$0.00+0.00%
ACURAcura Pharmaceuticals, Inc.
$0.00-66.67%
MRRCFWayland Group Corp.
$0.00+0.00%
ENDVEndonovo Therapeutics, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
ONDSOndas
$7.80-0.02%
SOFISoFi Technologies
$16.46-0.01%
TAT&T
$24.13+0.05%

Questions About NNRX

What is the current price of Nutranomics?

Nutranomics is trading at $0.00 per share.

What is the 52-week range for Nutranomics?

Over the past 52 weeks, Nutranomics has traded between $0.00 and $0.00.

How much debt does Nutranomics have?

As of the most recent reporting period, Nutranomics reported total debt of $19.75M.

How much cash does Nutranomics have on hand?

Nutranomics reported $344.80K in cash and cash equivalents in its most recent financial results.

What is Nutranomics’s dividend yield?

Nutranomics does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services